ArticleFrontiers in medicine2025
Cryptococcal pericarditis with unexplained lymphadenopathy in an immunocompetent patient: a case report.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To present a rare case of cryptococcal pericarditis with unexplained multiple lymphadenopathies in an immunocompetent patient. Background: Fungal pericarditis is an uncommon infection that may result from hematogenous dissemination, direct extension, or iatrogenic inoculation. Cryptococcal pericarditis typically occurs in immunocompromised hosts and is exceedingly rare in immunocompetent individuals. We describe a case of cryptococcal pericarditis with multiple lymphadenopathies in an immunocompetent patient. Case Report: A 40-year-old male with no underlying disease or history of high-risk behaviors presented with chronic cough and sputum production. Imaging revealed bilateral pulmonary lesions, widespread lymphadenopathy, and pericardial effusion. Serum and pericardial fluid cryptococcal antigen tests were positive. HIV testing (fourth-generation antigen/antibody ELISA) was negative, and immunologic evaluation was unremarkable. Pericardiocentesis drained 585 mL of effusion. The patient was treated with intravenous antifungal therapy with fluconazole (0.4 g daily) for 1 week, followed by oral fluconazole for 4 months. Follow-up echocardiography performed 2 weeks after discharge revealed no significant pericardial effusion, whereas a subsequent at 4 months after discharge demonstrated a small residual effusion. The patient's cough and sputum production had also improved. Throughout the hospitalization and post-discharge period, the patient was able to maintain normal physical activity without functional limitations. Conclusions: This report presents a rare case of cryptococcal pericarditis with unexplained multiple lymphadenopathies in an immunocompetent patient, highlighting that fungal infection should be considered even in immunocompetent hosts with pericarditis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.